Crispr'd Cells Show Promise in First US Human Safety Trial
Using genetically-edited cells to supercharge the immune system caused no adverse effects in cancer patients. It’s too soon to tell if it can be a cure.
Related articles
-
Dutch lawmaker Wilders appeals discrimination conviction
June 25, 2019 -
Kerr upset over 'bizarre' fouls late in Warriors loss
March 21, 2022 -
The best and worst MLS kits of all time
March 30, 2021
